|
1
|
Lin J, Wang Y, Zou YQ, Chen X, Huang B,
Liu J, Xu YM, Li J, Zhang J, Yang WM, et al: Differential miRNA
expression in pleural effusions derived from extracellular vesicles
of patients with lung cancer, pulmonary tuberculosis, or pneumonia.
Tumour Biol. Oct 14–2016. View Article : Google Scholar
|
|
2
|
Perepelyuk M, Maher C, Lakshmikuttyamma A
and Shoyele SA: Aptamer-hybrid nanoparticle bioconjugate
efficiently delivers miRNA-29b to non-small-cell lung cancer cells
and inhibits growth by downregulating essential oncoproteins. Int J
Nanomedicine. 11:3533–3544. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Aghanoori MR, Mirzaei B and Tavallaei M:
MiRNA molecular profiles in human medical conditions: Connecting
lung cancer and lung development phenomena. Asian Pac J Cancer
Prev. 15:9557–9565. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen Y, Du M, Wang J, Xing P, Zhang Y, Li
F and Lu X: MiRNA-200a expression is inverse correlation with
hepatocyte growth factor expression in stromal fibroblasts and its
high expression predicts a good prognosis in patients with
non-small cell lung cancer. Oncotarget. 7:48432–48442.
2016.PubMed/NCBI
|
|
5
|
Zhang X, Wang C, Shan S, Liu X, Jiang Z
and Ren T: TLR4/ROS/miRNA-21 pathway underlies lipopolysaccharide
instructed primary tumor outgrowth in lung cancer patients.
Oncotarget. 7:42172–42182. 2016.PubMed/NCBI
|
|
6
|
Zhao C, Lu F and Chen H, Zhao F, Zhu Z,
Zhao X and Chen H: Clinical significance of circulating miRNA
detection in lung cancer. Med Oncol. 33:412016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhou Z, Niu X, Li C, Sheng S and Lu S:
Inhibition of the growth of non-small cell lung cancer by
miRNA-1271. Am J Transl Res. 7:1917–1924. 2015.PubMed/NCBI
|
|
8
|
Bianchi F, Nicassio F, Marzi M, Belloni E,
Dall'olio V, Bernard L, Pelosi G, Maisonneuve P, Veronesi G and Di
Fiore PP: A serum circulating miRNA diagnostic test to identify
asymptomatic high-risk individuals with early stage lung cancer.
EMBO Mol Med. 3:495–503. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chen Y, Min L, Zhang X, Hu S, Wang B, Liu
W, Wang R, Gu X, Shen W, Lv H, et al: Decreased miRNA-148a is
associated with lymph node metastasis and poor clinical outcomes
and functions as a suppressor of tumor metastasis in non-small cell
lung cancer. Oncol Rep. 30:1832–1840. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen Z, Zeng H, Guo Y, Liu P, Pan H, Deng
A and Hu J: miRNA-145 inhibits non-small cell lung cancer cell
proliferation by targeting c-Myc. J Exp Clin Cancer Res.
29:1512010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gao W, Lu X, Liu L, Xu J, Feng D and Shu
Y: MiRNA-21: A biomarker predictive for platinum-based adjuvant
chemotherapy response in patients with non-small cell lung cancer.
Cancer Biol Ther. 13:330–340. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sestini S, Boeri M, Marchianò A, Silva M,
Calareso G, Galeone C, Sozzi G and Pastorino U: Lung cancer
screening in high-risk subjects: Early detection with LDCT and risk
stratification using miRNA-based blood test. Epidemiol Prev. 40 1
Suppl 1:S42–S50. 2016.(In Italian).
|
|
13
|
Feng ZJ, Gao SB, Wu Y, Xu XF, Hua X and
Jin GH: Lung cancer cell migration is regulated via repressing
growth factor PTN/RPTP β/ζ signaling by menin. Oncogene.
29:5416–5426. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Matkar S, Thiel A and Hua X: Menin: A
scaffold protein that controls gene expression and cell signaling.
Trends Biochem Sci. 38:394–402. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Duan Y, Hu L, Liu B, Yu B, Li J, Yan M, Yu
Y, Li C, Su L, Zhu Z, et al: Tumor suppressor miR-24 restrains
gastric cancer progression by downregulating RegIV. Mol Cancer.
13:1272014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Martin EC, Elliott S, Rhodes LV, Antoon
JW, Fewell C, Zhu Y, Driver JL, Jodari-Karimi M, Taylor CW,
Flemington EK, et al: Preferential star strand biogenesis of
pre-miR-24-2 targets PKC-alpha and suppresses cell survival in
MCF-7 breast cancer cells. Mol Carcinog. 53:38–48. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lynch SM, McKenna MM, Walsh CP and McKenna
DJ: miR-24 regulates CDKN1B/p27 expression in prostate cancer.
Prostate. 76:637–648. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang H, Duan J, Qu Y, Deng T, Liu R,
Zhang L, Bai M, Li J, Ning T, Ge S, et al: Onco-miR-24 regulates
cell growth and apoptosis by targeting BCL2L11 in gastric cancer.
Protein Cell. 7:141–151. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhao G, Liu L, Zhao T, Jin S, Jiang S, Cao
S, Han J, Xin Y, Dong Q, Liu X and Cui J: Upregulation of miR-24
promotes cell proliferation by targeting NAIF1 in non-small cell
lung cancer. Tumour Biol. 36:3693–3701. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gao Y, Liu Y, Du L, Li J, Qu A, Zhang X,
Wang L and Wang C: Down-regulation of miR-24-3p in colorectal
cancer is associated with malignant behavior. Med Oncol.
32:3622015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Pan B, Chen Y, Song H, Xu Y, Wang R and
Chen L: Mir-24-3p downregulation contributes to VP16-DDP resistance
in small-cell lung cancer by targeting ATG4A. Oncotarget.
6:317–331. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yoshida T, Hida T and Yatabe Y: Rapid and
dramatic response to alectinib in an anaplastic lymphoma kinase
rearranged non-small-cell lung cancer patient who is critically
ill. Anticancer Drugs. 27:573–575. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Huang ZL, Cao X, Luo RZ, Chen YF, Zhu LC
and Wen Z: Analysis of ERCC1, BRCA1, RRM1 and TUBB3 as predictors
of prognosis in patients with non-small cell lung cancer who
received cisplatin-based adjuvant chemotherapy: A prospective
study. Oncol Lett. 11:299–305. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chen L, Luo L, Chen W, Xu HX, Chen F, Chen
LZ, Zeng WT, Chen JS and Huang XH: MicroRNA-24 increases
hepatocellular carcinoma cell metastasis and invasion by targeting
p53: miR-24 targeted p53. Biomed Pharmacother. 84:1113–1118. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Dong X, Ding W, Ye J, Yan D, Xue F, Xu L,
Yin J and Guo W: MiR-24-3p enhances cell growth in hepatocellular
carcinoma by targeting metallothionein 1M. Cell Biochem Funct.
34:491–496. 2016. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ye SB, Zhang H, Cai TT, Liu YN, Ni JJ, He
J, Peng JY, Chen QY, Mo HY, Jun-Cui, et al: Exosomal miR-24-3p
impedes T-cell function by targeting FGF11 and serves as a
potential prognostic biomarker for nasopharyngeal carcinoma. J
Pathol. 240:329–340. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li Q, Wang N, Wei H, Li C, Wu J and Yang
G: miR-24-3p regulates progression of gastric mucosal lesions and
suppresses proliferation and invasiveness of N87 via peroxiredoxin
6. Dig Dis Sci. 61:486–3497. 2016. View Article : Google Scholar
|
|
28
|
Zhao J, Hu C, Chi J, Li J, Peng C, Yun X,
Li D, Yu Y, Li Y, Gao M and Zheng X: miR-24 promotes the
proliferation, migration and invasion in human tongue squamous cell
carcinoma by targeting FBXW7. Oncol Rep. 36:1143–1149. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li YQ, Lu JH, Bao XM, Wang XF, Wu JH and
Hong WQ: MiR-24 functions as a tumor suppressor in nasopharyngeal
carcinoma through targeting FSCN1. J Exp Clin Cancer Res.
34:1302015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Du WW, Fang L, Li M, Yang X, Liang Y, Peng
C, Qian W, O'Malley YQ, Askeland RW, Sugg SL, et al: MicroRNA
miR-24 enhances tumor invasion and metastasis by targeting PTPN9
and PTPRF to promote EGF signaling. J Cell Sci. 126:1440–1453.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Veschi S, Lattanzio R, Aceto GM, Curia MC,
Magnasco S, Angelucci D, Cama A, Piantelli M and Battista P:
Alterations of MEN1 and E-cadherin/β-catenin complex in sporadic
pulmonary carcinoids. Int J Oncol. 41:1221–1228. 2012.PubMed/NCBI
|
|
32
|
Wu Y, Feng ZJ, Gao SB, Matkar S, Xu B,
Duan HB, Lin X, Li SH, Hua X and Jin GH: Interplay between menin
and K-Ras in regulating lung adenocarcinoma. J Biol Chem.
287:40003–40011. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔCT method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Pfaffl MW: A new mathematical model for
relative quantification in real-time RT-PCR. Nucleic Acids Res.
29:e452001. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yang TS, Yang XH, Wang XD, Wang YL, Zhou B
and Song ZS: MiR-214 regulate gastric cancer cell proliferation,
migration and invasion by targeting PTEN. Cancer Cell Int.
13:682013. View Article : Google Scholar : PubMed/NCBI
|
